Investigation of Anti-Toxocara and Anti-Toxoplasma Antibodies in Patients with Schizophrenia Disorder

Table 7

The distribution of latent toxoplasmosis according to the age in patients with schizophrenia disorder and healthy controls.

	Patients’ group	Healthy	Sig	OR	CI95
	𝑁 (%)	𝑁 (%)
Age (years)
<20	0 (0%)	0/4 (0%)
20–29	10/32 (32.25%)	37/83 (44.57%)	0.1	2.9	0.68–12.51
30–39	14/34 (41.17%)	5/7 (71.42%)	0.1	0.2	0.04–1.5
40–49	6/23 (26.08%)	0/0 (0%)
>50	4/11 (36.36%)	1/1 (100%)	0.4	0.3	0.1–0.7